ZA72252B - A process for the preparation of new complexes of biologically active peptides polypetides,proteins or derivatives or salts thereof having prolonged or increased activity - Google Patents

A process for the preparation of new complexes of biologically active peptides polypetides,proteins or derivatives or salts thereof having prolonged or increased activity

Info

Publication number
ZA72252B
ZA72252B ZA720252A ZA72252A ZA72252B ZA 72252 B ZA72252 B ZA 72252B ZA 720252 A ZA720252 A ZA 720252A ZA 72252 A ZA72252 A ZA 72252A ZA 72252 B ZA72252 B ZA 72252B
Authority
ZA
South Africa
Prior art keywords
polypetides
prolonged
proteins
derivatives
salts
Prior art date
Application number
ZA720252A
Other languages
English (en)
Inventor
G Hajos
L Szporny
I Gebhardt
G Takacsi
G Fekete
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of ZA72252B publication Critical patent/ZA72252B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/14—Enzymes or microbial cells immobilised on or in an inorganic carrier
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/085—Angiotensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A61K38/35—Corticotropin [ACTH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/52—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an inorganic compound, e.g. an inorganic ion that is complexed with the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Endocrinology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Vascular Medicine (AREA)
  • Microbiology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
ZA720252A 1971-01-20 1972-01-14 A process for the preparation of new complexes of biologically active peptides polypetides,proteins or derivatives or salts thereof having prolonged or increased activity ZA72252B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HURI000418 1971-01-20

Publications (1)

Publication Number Publication Date
ZA72252B true ZA72252B (en) 1972-09-27

Family

ID=11000857

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA720252A ZA72252B (en) 1971-01-20 1972-01-14 A process for the preparation of new complexes of biologically active peptides polypetides,proteins or derivatives or salts thereof having prolonged or increased activity

Country Status (10)

Country Link
AU (1) AU3784072A (xx)
BE (1) BE778239A (xx)
CA (1) CA972288A (xx)
DD (1) DD98915A5 (xx)
DE (1) DE2202176A1 (xx)
ES (1) ES399033A1 (xx)
FR (1) FR2122529A1 (xx)
IL (1) IL38546A0 (xx)
NL (1) NL7200716A (xx)
ZA (1) ZA72252B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS563846B2 (xx) * 1972-10-12 1981-01-27
GB1576376A (en) * 1977-03-30 1980-10-08 Benzon As Alfred Multiple-unit drug dose
DE3230736A1 (de) * 1982-08-18 1984-02-23 Herbert Prof. Dr. 8400 Regensburg Rupprecht An siliciumdioxid als traeger gebundene wirkstoffe, verfahren zu ihrer herstellung und ihre verwendung
DE3502099A1 (de) * 1985-01-23 1986-08-07 Dieter Prof. Dr. Dr. 5883 Kierspe Aderhold Therapeutisches, peptid- und/oder aminosaeurehaltiges mittel
US5130298A (en) * 1989-05-16 1992-07-14 Ethicon, Inc. Stabilized compositions containing epidermal growth factor
FR2799758B1 (fr) * 1999-10-15 2002-05-17 Exsymol Sa Complexe a base d'acide orthosilicique biologiquement assimilable, se presentant sous forme solide, stable et concentree, et procede de preparation

Also Published As

Publication number Publication date
IL38546A0 (en) 1972-03-28
ES399033A1 (es) 1975-05-16
CA972288A (en) 1975-08-05
FR2122529B1 (xx) 1975-12-26
DD98915A5 (xx) 1973-07-12
FR2122529A1 (en) 1972-09-01
DE2202176A1 (de) 1972-08-03
NL7200716A (xx) 1972-07-24
BE778239A (fr) 1972-05-16
AU3784072A (en) 1973-07-19

Similar Documents

Publication Publication Date Title
HU172927B (hu) Sposob poluchenija azolil-/1/-metanov, ikh solej i lechebnykh preparatov soderzhahhikh takoe aktivnoe vehhestvo
HU173417B (hu) Sposob poluchenija lechebnykh preparatov
SE415660B (sv) Forfarande for framstellning av biologiskt aktiva, berarbundna proteiner
PH11575A (en) Imidazolyl-o,n-acetals and their salts,processes for their preparation and their use as fungicides
ZA726402B (en) New cyclic urea derivatives and salt thereof,process for the production thereof and pharmaceutical preparations containing the same
ZA72252B (en) A process for the preparation of new complexes of biologically active peptides polypetides,proteins or derivatives or salts thereof having prolonged or increased activity
AU462701B2 (en) Polymer biologically active protein complexes
ZA755956B (en) Dipeptide derivatives, a process for the manufacture thereof and pharmaceutical preparations containing such compounds
NL179816C (nl) Werkwijze ter bereiding van een farmaceutisch preparaat met een beta-blokkeringsactiviteit, alsmede de aldus vervaardigde farmaceutische voorwerpen, en werkwijze ter bereiding van nieuwe 5-(2-hydroxy-3-gesubstitueerd amino)propoxy-carbostyril- of 3.4-dihydrocarbostyril-verbindingen of de zouten daarvan.
CA1019336A (en) Process for the preparation of bimetallic salt complexes
EG11309A (en) A process for the preparation of biologically active polypeptides containing aspartyl group
CA977774A (en) Process for the preparation of guanidine
ZA738556B (en) Nutrient protein from keratinaceous material
AU467984B2 (en) Biologically active two-component complexes
IL42973A0 (en) Peptides of acth activity containing alpha-aminooxy carboxylic acid on the n-terminal moiety,and a process for the preparation thereof
AU469525B2 (en) Biologically active di-aryl compounds
NL7503282A (nl) Werkwijze ter bereiding van aminosuikerderivaten bevattende diervoederpreparaten.
IL45779A (en) 1-oxo-2-aryl or thienyl-2-substituted-5-indanyloxy-alkanoic acids and derivatives thereof,processes for their preparation and pharmaceutical compositons containing them
HU172245B (hu) Sposob poluchenija proizvodnykh 1,4-digidro-2h-izokhinolina s osnovnym zamestitelem i lechebnykh preparatov soderzhahhikh takie akyivnye sostavljajuhhie
AU6233573A (en) Process for preparing salt stable latices
NL7501942A (nl) Werkwijze ter bereiding van 2-alkylglycerol- derivaten bevattende biologisch werkzame preparaten.
HU171384B (hu) Sposob poluchenija biologicheski aktivnykh proizvodnykh pteridina
EG11385A (en) Process for preparing of 1-phenyl-2-(1'1'-diphenylpropyl(3')-amino)-propanes
CA1026768A (en) Process for the production of guanidine salts of aliphatic mercaptosulphonic acids
HU172076B (hu) Sposob poluchenija novykh farmacevticheskikh preparatov dlja umen'senija vysokogo davlenija krovi